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Introduction
The gene mutated in the lethal genetic disease, cystic fibrosis (CF), was identified in 1989. 1 The protein for which it codes, the cystic fibrosis transmembrane conductance regulator (CFTR) is now known to function as a chloride channel on the apical surface of epithelial cells lining affected organs. 2 The elucidation of the molecular basis of the disease has opened the way for the development of gene therapy for this disease. Direct delivery of the CFTR transgene to the airways of patients by aerosolisation is likely to be the most efficient route. Compared to intratracheal instillation, nebulisation is non-invasive and capable of widespread droplet deposition likely to reach the epithelium lining peripheral conducting airways, an important site of disease in CF subjects. Nebulisation provides the further advantage of prolonged contact time between the gene complexes and the airway surface epithelium, a factor likely to play an important role in gene transfer efficiency. Finally, delivery of gene therapy by this route is likely to be most acceptable for CF patients, particularly if routine repeated applications of gene therapy to the lower airways is required.
Despite these obvious advantages, there have been concerns about the effects of the nebulisation process on the functional integrity of the DNA-gene transfer complex. Conformational changes caused by the sheer stresses of nebulisation may adversely affect gene transfer efficiency. 3 Changes in the concentration of the nebulised solute which occur during nebulisation due to evaporation of the diluent, represent a further potential problem. 4 Furthermore, where cationic liposomes are used as the gene delivery vehicle, the presence of charged particles in an aerosol can alter the effective aerosol droplet size. 5 We have previously reported a phase I clinical trial of cationic liposome-mediated gene transfer to the nasal epithelium of CF patients. 6 This study demonstrated a small but measurable correction of the CF chloride defect in the treated nasal epithelia. Following this study we have undertaken a trial of cationic liposome-mediated transfer of CFTR-cDNA to the lower airways of CF patients by nebulisation. Given the potential problems noted above, we have studied the effects of jet nebulisation on liposome-mediated gene transfer directly on to epithelial cell lines in vitro. Using an Acorn System 22 nebuliser (Medicaid, Pagham, UK) to transfer the reporter gene encoding ␤-galactosidase (pCMV␤) 7 complexed with the cationic liposome DC-cholesterol/DOPE, 8 we demon-strate that the process of nebulisation itself does not necessarily have an adverse effect on gene transfer efficiency in vitro. The outcome of gene transfer however, appears to be dependent on the formulation of DNAlipid complexes to be nebulised and also, in part, on the nature of the gas mixture used to drive the nebuliser.
Results
Collection efficiency of the apparatus The efficiency of DNA delivery from the nebuliser to the recipient cells was calibrated by nebulising a known amount of complexed pCMV␤/DC-Chol/DOPE (20 g pCMV␤/100 g DC-Chol/DOPE) into the flask containing 5 ml of water and found to be 41.5 ± 2.1% (mean ± s.e.m., n = 6) ( Figure 1 ). When 5 ml was nebulised into the flask containing 5 ml, the resulting final volume remained fairly constant at approximately 5 ml, due both to evaporation from the nebulisate and from the recipient culture medium during nebulisation.
Nebulisation of DNA-liposome complexes directly on to cells in vitro is associated with improved transfection efficiency Compared with control conditions in which cells were transfected with DNA-liposome complexes by instillation (8 g pCMV␤ complexed with 40 g DCChol/DOPE per flask), nebulisation of the complexes directly on to the cells at a final equivalent dose based on the calibrated collection efficiency of approximately 40% (20 g pCMV␤ complexed with 100 g DCChol/DOPE nebulised on to each flask), resulted in a significant (P Ͻ 0.05) improvement in transfection efficiency in all three cell lines tested ( Figure 2 ).
Nebulisation of the complex using 95% O 2 /5% CO 2 contributes to the improved transfection efficiency In order to elucidate possible factors contributing to the improved transfection efficiency observed following nebulisation, three factors were investigated: (1) the comparative effects of an air mixture (21% O 2 /78% N 2 ) and 95% O 2 /5% CO 2 to drive the nebuliser; (2) the physical consequences of the nebulisation process itself upon the cells before transfection; and (3) the effects of nebulisation on the DNA-liposome complexes before instillation on to the cells. Using 16HBEo− cells, the improved transfection efficiency previously demonstrated following nebulisation using 95% O 2 /5% CO 2 , was not sustained with the use of an air mixture ( Figure 3a) . Nebulisation of the cells with culture medium alone to simulate the physical effects of nebulisation followed by instillation of the pCMV␤/DC-Chol/DOPE resulted in transfection efficiency that was not significantly different to control cells transfected by instillation alone (Figure 3b ). This effect was similar regardless of whether 95% O 2 /5% CO 2 or an air mixture was used to drive the nebuliser.
Formulation of the DNA-liposome complexes is a critical determinant of nebuliser-mediated transfection efficiency In one particular set of experiments, nebulisation of the DNA-liposome complexes into medium alone followed by instillation of the nebulisate on to cells resulted in significantly poorer transfection than previously noted ( Figure 4a ). The only alteration in this experiment was to nebulise a six-fold concentration of the DNA-liposome complex (120 g pCMV␤ complexed with 600 g DCChol/DOPE with the aim of distributing the nebulisate between six flasks (20 g per flask). The observed results suggested that the increasing starting concentration of DNA-liposome nebulised might have contributed to the poor transfection efficiency. In a separate experiment, transfection efficiency was inversely related to increasing concentrations of DNA-liposome complex placed in the nebuliser (Figure 4b ). Expression of ␤-galactosidase was highest following nebulisation of 20 g pCMV␤/100 g DC-Chol/DOPE diluted in 5 ml OptiMEM which was then collected and instilled on to single flasks of cells. In comparison, nebulisation of 60 g pCMV␤/300 g DCChol/DOPE diluted in 5 ml OptiMEM, collected and instilled on to six flasks of cells resulted in significantly (P Ͻ 0.05) poorer transfection. Following nebulisation of 120 g pCMV␤/600 g DC-Chol/DOPE diluted in 5 ml OptiMEM, which was collected and instilled on to six flasks of cells, there was no detectable ␤-galactosidase expression.
Nebulisation of more highly concentrated DNA-liposome complexes was associated with less efficient delivery of DNA in the nebulisate, although the final amount reaching the recipient cells was not significantly different from that demonstrable when lower concentration complexes were nebulised At a constant 1:5 ratio of DNA:liposome (weight:weight), the concentration of DNA-liposome complexes correlates (r 2 = 0.997) with particle count rate (KCps) measured for each sample by the Zetasizer (see Materials and methods) ( Figure 5 ). However, above a final DNA concentration of approximately 3 g/ml, this relationship becomes nonlinear. Since the measured KCps for each nebulisate lay within the linear portion of the curve, KCps were used to extrapolate the final concentration of DNA reaching the cells. As depicted in Figure 5 , collection efficiency decreased as the concentration of the complexes to be nebulised increased. Thus, when the most highly concentrated (24 g/ml) complexes were nebulised, approximately 6% of DNA reached the cells and when the intermediate (15 g/ml) concentration of complexes were nebulised, approximately 16% of the original DNA reached the cells. Nevertheless, although these collection efficiencies were lower than the 40% derived from nebulisation of the lowest concentration (4 g DNA/ml), the final absolute amount of DNA reaching the recipient cells was not significantly different from the latter; indeed at the medium concentration, the absolute amount was greater. Thus the decrease in transfection efficiency associated with nebulisation of higher concentrations of complexes could not simply be attributed to a reduced DNA dose available for transfection.
The zeta potential of pCMV␤-DC-Chol/DOPE decreases with increasing concentration but no further changes occur following nebulisation At a constant 1:5 ratio of DNA:liposome (weight:weight), decreasing concentrations of DNA-liposome complexes were associated with a small but significant increase in the zeta potential (ie. from negative towards neutral) ( Figure 6a ). By using KCps as a measure of final concentration (see above), it was possible to compare measurements of zeta potential made before and after nebulisation at a given concentration (Figure 6b ). Compared with baseline, there was no significant difference in the zeta potential following nebulisation of the complexes at DNA concentrations previously demonstrated to result in good transfection efficiency (4 g/ml or 12 g/ml). Similar measurements made after nebulisation of high concentration complexes (24 g/ml) previously associated with undetectable transfection were neither significantly different from the low concentration nebulisate, nor different to baseline zeta potential before nebulisation ( Figure 6b ). These observations were similar regardless of whether the nebuliser was driven by 95% O 2 /5% CO 2 or an air mixture (data not shown).
The size of the DNA-liposome complexes remained stable over time and with varying DNA concentration and showed no significant change following nebulisation with either 95% O 2 /5% CO 2 or air There was no significant difference between the size of complex at the different concentrations chosen ( Figure  7a ). There were also no significant differences measurable following nebulisation of the complexes at each of the three concentrations chosen using either 95% O 2 /5% CO 2 or air to drive the nebuliser (Figure 7b ).
Nebulisation of complexes is associated with a significant decrease in temperature which occurs regardless of whether 95% O 2 /5% CO 2 or air is used to drive the nebuliser As might be expected, the temperature of the culture medium decreased during the course of nebulization ( Figure 8 ). While the decrease following nebulisation using air was significantly (P Ͻ 0.05) greater than the decrease demonstrable following nebulisation with 95% O 2 /5% CO 2 , the difference in absolute terms was approximately 1°C, which was unlikely to account for the associated differences in transfection efficiency.
Nebulisation using 95% O 2 /5% CO 2 but not air to drive the nebuliser was associated with a significant decrease in the pH of the culture medium which persisted for up to 6 h but which itself could not be shown to underlie improved transfection efficiency While the pH of the culture medium remained unchanged by nebulisation of complexes using an air mix containing air to drive the nebuliser, the use of 95% O 2 /5% CO 2 was associated with a significant (P Ͻ 0.01) decrease in pH (Figure 9a ). Following return of the cell culture flasks to an incubator environment of 37°C/5% CO 2 , equilibration of the medium to a pH of approximately 7.4 took 61 ± 6 min (n = 6). However, when cells were maintained under simulated nebuliser conditions for this time period (ie OptiMEM adjusted to a pH of 6.5) and then transfected by instillation of DNA complexes into medium of pH 7.4, no significant improvement in transfection efficiency was observed compared with control cells which had not been subjected to an altered pH environment, suggesting that the reduced pH did not produce an effect directly on the cell membrane to facilitate transfection.
Discussion
In this study we have used a novel collecting system to demonstrate that nebulisation of DNA-liposome complexes does not compromise transfection efficiency. Indeed, compared with instillation, nebulisation of complexes directly on to epithelial cell lines in vitro was associated with improved transfection efficiency in all three cell lines tested. The success of gene transfer by nebulisation appeared, however, to be dependent on at least two factors: the formulation of the complexes to be nebulised and the nature of the gas mixture used to drive the nebuliser. Nebulisation of higher concentrations of DNAliposome was associated with poorer transfection efficiency. Poor transfection could not simply be attributed to inadequate delivery of DNA to recipient cells; nor were changes in zeta potential or the mean size of the complexes demonstrable in relation to different concentrations of complex nebulised. With respect to improved gene transfer efficiency, the use of 95% O 2 /5% CO 2 was associated with a decrease in pH of the bathing medium of the cells. However, this factor in itself did not explain the improved gene transfer efficiency.
Successful transfer of DNA-cationic liposome complexes to the lungs of animals by nebulisation has been well documented. CAT expression was demonstrated in the lungs of mice following delivery as cationic liposome-plasmid complex via aerosol. 9 Similarly, human a 1 -antitrypsin (AAT) expression was shown in rabbit lungs for up to 7 days following aerosol transfection with an AAT-DNA construct complexed with the cationic liposome Lipofectin (Gibco, Gaithersburg, MD, USA). 10 We have demonstrated restoration of cAMP-mediated chloride transport following delivery of CFTR cDNA complexed with DC-Chol/DOPE by nebulisation in CF mice. 11 The results of these studies, together with the obvious advantages of nebulisation compared with instillation for delivery of topical gene therapy to the lower airways of human subjects, suggests that nebulisation is likely to be the most practical and efficient route of delivery for respiratory gene therapy. There have been recently reported studies on the effects of the nebulisation process on DNA-liposome complexes 3 and on optimisation of formulation of a specific cationic liposome-DNA complex for nebulisation. 12 However, there are to date no reported studies directly comparing transfection efficiency of instillation and nebulisation, nor the specific mechanisms underlying the differences between them that might need to be addressed in order to ensure optimal delivery and transfer of the gene to the lungs in clinical practice.
No in vitro model can be directly comparable to in vivo gene transfer. However, the advantage of the adapted culture flasks for the experiments described was that collection of the DNA-liposome aerosol directly on to the epithelial cell monolayers permitted a closer simulation of the in vivo situation than collection and instillation of nebulised complexes on to the cells. 3 Furthermore, estimation of the collection efficiency of the apparatus made it possible to compare directly the transfection efficiency following nebulisation with that following instillation of a given amount of DNA. The nebuliser used (Acorn System 22) is one currently in widespread clinical use for the delivery of antibiotics and bronchodilators in cystic fibrosis. It is well characterized with respect to particle size distribution (77% within the respirable fraction of Ͻ5 m during inspiration) 13 and is thus likely to achieve reasonable particle deposition to the peripheral conducting airways, likely to be targeted for CF gene therapy.
The improved transfection efficiency demonstrated using this system compared with instillation of pCMV␤/DC-Chol/DOPE was encouraging but also sur- 20 (v) prising in the light of the potential deleterious effect that nebulisation might have on the functional integrity of the complexes. 3 A number of mechanisms that might have contributed to the improvement were addressed. Of these, the effect of DNA-liposome formulation before nebulisation proved the most important determinant of transfection efficiency. Various factors were therefore considered to explain the poor transfection efficiency associated with nebulisation of highly concentrated complexes, including the possibility that the poor transfection simply reflected poor delivery of DNA from the nebuliser to the cells. Measurement of KCps of the complex suspension before and after nebulisation revealed that collection efficiency of the apparatus, although calibrated at approximately 40% for the low concentration of complex studied (20 g DNA per 100 g liposome), was much less when highly concentrated complex was nebulised. This factor however was insufficient to explain the degree of transfection loss. Despite the lower collection efficiency, the absolute amount of DNA (approximately 2 g DNA/ml) reaching the recipient cells was not significantly different from that reaching the cells following nebulisation of the low concentration complex which was associated with good transfection efficiency. Furthermore, this concentration of pCMV␤/DC-Chol/DOPE has been shown in independent studies using DCChol/DOPE to result in optimal transfection of 16HBEo − cells.
Figure 6 The effect of concentration and nebulisation on zeta potential. Serial dilutions of pCMV␤-DC-Chol/DOPE at a constant ratio of 1:5 (wt:wt) were made and the zeta potential measured as described (see Materials and methods) to yield a baseline plot (s) of charge (mV) against concentration of complexes (a) and then against KCps (b) (mean ± s.e.m., n = 6). Measurements of zeta potential were then made on nebulised samples derived from solutions containing 120 (b), 60 (२) and
14 No significant changes in mean particle size were demonstrable either in relation to changes in complex concentration or following nebulisation using either 95% O 2 /5% CO 2 or an air mixture to drive the nebuliser. This suggests that the expected shearing of the complexes by the effects of nebulisation did not occur and concurs with previous reports that cationic liposomes protect the DNA from these effects. 3, 12 Furthermore, these observations make it unlikely that the low KCps measured after nebulisation of highly concentrated complex reflect flocculation of the complexes where an increase in the mean particle size would have been expected.
No significant change in zeta potential was documented following nebulisation. Zeta potentials provide a measure of surface charge of the complex, a function of the relative contributions of the negatively charged plasmid and cationic lipid present, and may vary within a range of approximately −40 mV to +50 mV for different cationic lipids. 15, 16 Zeta potential has previously been shown to correlate with cationic liposome-mediated transfection efficiency in vitro, with more positive charge associated with better transfection. 17 In contrast it has also recently been reported that optimal transfection following nebulisation occurs when the cationic lipid:DNA formulation exhibits a highly negative charge and that as the charge on the complex approaches neutrality, precipitation is seen to occur.
12 DC-Chol is a tertiary amine with a pK a of around 7, 16 whereas DOTAP, another cationic liposome used for gene delivery, is a quaternary amine. This results in an effective zeta potential of close to neutral for DC-Chol-based products but a strongly positive charged DOTAP-based product (+30 mV to +50 mV), 15 despite the fact that the DNA:liposome ratios usually used for each are nominally similar (1:5 w/w for DCChol and 1:6 w/w for DOTAP). Thus, while zeta potential was not shown to be a critical determinant of the transfection differences observed for different concentrations of the components used in this study, optimising the formulation of different components for gene transfer may involve an evaluation of zeta potential profiles. Further, it has also been shown that maintenance of the ratio of DNA:lipid following nebulisation may determine transfection efficiency following nebulisation. 12 This study suggests that the most efficient gene transfer occurs when an initially optimised DNA:lipid ratio is maintained through nebulisation and that this is best achieved by using an ionic medium for suspension of the complexes. The effect of ionic strength on the the zeta potential may in part account for these effects. However, the inital concentration of the complexes to be nebulised may in part determine how well the DNA:lipid ratio is maintained throughout nebulisation. Thus formulation of complexes for optimal gene transfer by nebulisation should also involve an evaluation of this parameter.
The observations of this study suggest an advantage in using 95% O 2 /5% CO 2 to drive the nebuliser and might usefully inform a choice to use this gas mixture for clinical gene transfer to patients' lower airways. The mechanisms underlying the observed improvement in transfection efficiency however, remains unclear. In view of the relatively high CO 2 content of this mixture, it was not surprising to find that the pH of the cell environment dropped significantly following nebulisation -a process which itself lasted up to 15 min. This raised the possibility that exposure of the cells to this acute pH change, either alone or in combination with the marked drop in temperature, resulted in cell surface changes that were advantageous for entry of the DNA-liposome complex into the cells and which persisted in the incubator for long enough after nebulisation to affect transfection. Thus in order to determine the effect of environmental pH on transfection efficiency, flasks of cells maintained initially under incubator conditions of 37°C/5% CO 2 , were exposed respectively to a range of pH conditions for up to 1 h and then transfected by instillation as usual. While the results demonstrate that at extremes of enviromental pH (5 or 8), transfection efficiency is adversely affected, pH changes similar to those seen following nebulisation, were not associated with improved transfection. We have previously reported that the pH at which the DNAliposome complex is formed is a critical determinant of transfection efficiency in vitro.
14 It is therefore possible that the beneficial effect of nebulisation with 95% O 2 /5% CO 2 relates to changes induced in the complex by the brief period of acidification.
Figure 9 The effect of nebulisation on the pH of the cell environment and the effect of cell-environmental pH on transfection efficiency in vitro. The pH (a) of the medium surrounding the cells was measured before (solid bars) and after nebulisation (white bars) using either 95% O
2 /5% CO 2 (n = 6) or 21% O 2 /78% N 2 (n = 6)
Materials and methods

Cells
All media and supplements were obtained from Gibco BRL, Paisley, UK. The SV-transformed renal epithelial cell line Cos 7 (derived from African Green Monkey) 18 was maintained at 37°C/5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 1% l-glutamine and 1% penicillin/streptomycin. The human bronchial epithelial cell line (16HBE14o − ) 19 and the CF submucosal epithelial cell line (2CFSMEo − ) 20 were maintained in minimum essential medium (MEM) supplemented with 10% FBS, 1% penicillin/streptomycin, 1% l-glutamine and nonessential amino acids.
Plasmid DNA and cationic liposomes
The eukaryotic expression plasmid pCMV␤ (Clontech Laboratories, Palo Alto, CA, USA) 7 containing the Escherichia coli ␤-galactosidase gene under the control of the cytomegalovirus immediate-early promoter and enhancer was used to assess transgene expression after cell transfection. Plasmid DNA was prepared as described previously. 21 DC-Chol was prepared using the method of Gao and Huang 8 and the cationic liposome DC-Chol/DOPE was prepared by microfluidisation and diluted to a final concentration of 2 mol/ml (1.2 mg/ml total lipid).
Nebulisation and collection system An Acorn System 22 nebuliser (Medicaid) driven either by 95% O 2 /5% CO 2 or by an air mixture containing 21% oxygen/78% nitrogen at 6 l/min was used. A T-50 ml cell culture flask (Greiner Labortechnik, Dursley, UK) was adapted to collect the aerosol (Figure 1 ). The apparatus was calibrated for collection efficiency by nebulising a known amount of complexed pCMV␤/DC-Chol/DOPE (20 g pCMV␤/100 g DC-Chol/DOPE) into the flask containing 5 ml of water. The collected sample was treated with Triton-X (0.1%) (Sigma, Poole, UK) to disrupt the liposome component and assayed for the presence of DNA using a UV spectrometer at a wavelength of 260 nm, blanked using 0.1% Triton-X.
Cell transfection (a) By instillation: Cells were plated in T-50 ml flasks (Greiner Labortechnik) and maintained at 37°C/5% CO 2 until 60-70% confluent in their respective growth media. Cells were washed with PBS (pH 7.4) and the medium replaced with 5 ml of OptiMEM. The DNA and liposomes were complexed by mixing of the two components at a ratio of 1:5 weight:weight DNA:liposome. The complexes were mixed for each flask individually and immediately pipetted into the 5 ml bathing medium covering the cells (8 g DNA:40 g liposome made up to 100 l in OptiMEM per flask). Even distribution of the complexes over the cell culture surface was achieved by gentle shaking of the flask. Medium was removed 18-24 h after transfection, the cells were washed twice with PBS and the medium replaced with the appropriate normal growth medium.
(b) By nebulisation of DNA-liposome complexes: Cells were plated as above in T-50 ml flasks from which the lids had been adapted for removal ( Figure 1 ) and maintained in culture until 60-70% confluent, washed and replaced with OptiMEM as above. The DNA and liposomes (20 g DNA per flask to account for the collection efficiency of approximately 40%) were complexed as above before suspension in 5 ml OptiMEM and then nebulised to dryness on to the cells via the adapted flask lid. Media was removed 18-24 h after transfection, the cells were washed twice with PBS and the medium replaced with the appropriate normal growth medium.
(c) By instillation following exposure of the cells to nebulised culture medium: Cells were prepared as in (b) and then exposed to nebulisation of 5 ml OptiMEM alone before instillation of DNA-liposome complexes (8 g DNA per flask) as described in (a).
(d) By instillation of DNA-liposome complexes which had been nebulised and collected: The DNA and liposomes were complexed as described in (a), suspended in 5 ml OptiMEM (120 g DNA/5 ml) and nebulised into a collecting flask containing only OptiMEM. The collected nebulisate was instilled on to a flask of cells unexposed to nebulisation. The final volume of the high-dose nebulisate in each flask was equivalent to the volume used for the low-dose nebulisate.
␤-Galactosidase assay
The cells were assayed for ␤-galactosidase activity using a photometric assay previously described. 22 Briefly, 48 h after transfection the cells were lysed in a solution containing 0.1% Triton X-100 and 250 mm Tris (pH 8, 350 l per well), frozen at −70°C and thawed at room temperature. Fifty microlitres of cell lysate from each well was transferred to a 96-well plate and to each well was added: 50 l PBS containing 0.5% BSA, 150 l chlorophenol red galactopyranoside (1 mg/ml in a buffer containing 60 mm Na 2 HPO 4 , 1 mm MgSO 4 , 10 mm KCl and 50 mm ␤-mercaptoethanol). Following 60-min incubation at 37°C, the plate was read at 578 nm in a microtitre plate. Absorption readings were converted to pg of ␤-galactosidase using a standard curve of ␤-galactosidase. To minimize the effects of differing cell numbers and cell growth, the amount of ␤-galactosidase expression obtained was standardized by calculation of the amount of protein present in each cell lysate. Protein was assayed using the Bradford method 23 in a microassay protocol adapted for use in 96-well plates (Bio-Rad, Hemel Hempstead, UK) read at 595 nm. Absorption readings were converted to microgrammes protein using a bovine serum albumin standard curve and data expressed as pg ␤-galactosidase per microgramme protein.
Measurement of zeta potential
Zeta potential was measured by laser Doppler spectroscopy using a Malvern Zetasizer (Malvern Instruments, Malvern, UK). Samples were prepared in Opti-MEM and serially diluted to establish baseline measurements of zeta potentials associated with DNAliposome concentrations ranging from 25 g pCMV␤/125 g DC-Chol-DOPE to 1 g pCMV␤/5 g DC-Chol-DOPE.
Measurements made at concentrations below 1 g/ml DNA/5 g/ml liposome were excluded because of the inaccuracy of charge measurements made under very dilute conditions. KCps were recorded as each measurement was made and correlated with sample concentration.
To assess the effect of nebulisation on the complex, the DNA-liposome solution was suspended in OptiMEM and the flask collection system was filled with 5 ml Opti-MEM for collection of the nebulisate. Samples were analysed both after nebulisation driven by 95% O 2 /5% CO 2 and by an air mixture.
Measurement of temperature and pH following nebulisation Cells were prepared in adapted tissue culture flasks as described above. DNA-liposome complexes suspended in OptiMEM were nebulised as described above using either 95% O 2 /5% CO 2 (n = 6) or air (n = 6) to drive the nebuliser. pH was recorded just before and immediately after nebulisation was complete. Temperature was monitored throughout by placing a probe attached to a digital thermometer (Thermometer 2102; Jenway, Dunmow, UK) within the tissue culture flask for the duration of nebulisation.
The effect of pH on transfection efficiency OptiMEM was adjusted to pH 5, 6, 6.5, 7 and 8 by addition of either 5 m HCl or 5 m NaOH. The adjusted medium was then passed through a 0.2 filter and cooled to approximately 15°C, the temperature to which the medium is cooled by nebulisation. Cells were plated as above in T-50 ml flasks and maintained in culture until 60-70% confluent. After washing, medium was replaced with adjusted OptiMEM and kept at room temperature for 15 min (the duration of nebulisation) before replacement in the incubator at 37°C/5% CO 2 for a further 45 min. The cells were then washed, replaced with nonadjusted OptiMEM and transfected by instillation as described above.
Size analysis
The mean hydrodynamic diameter and the size distribution were measured by laser light scattering (Malvern Zetasizer) at a 90°angle. The size of the complex was measured before and after nebulisation with 95% O 2 /5% CO 2 or air and the effect of different initial concentrations of complex assessed.
Statistics
The data are presented as mean ± s.e.m. for convenience, where n refers to numbers of repeat experiments (usually n = 6). The Mann-Whitney U test was used for comparisons between interventions and the null hypothesis rejected at P Ͻ 0.05.
